Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
Clinical trial NCT04572685 · COMPLETED
Trial details
- NCT number
- NCT04572685
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2020-06-26
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.